Dr. Jerome Coffey:

Obviously the focus has recently been on CervicalCheck but the HSE intends to review patient safety across all screening programmes - the three programmes for cancers and the programme for diabetic retinopathy. We are currently sourcing some international screening experts to support these programmes. Separately, we are conscious that Dr. Scally will be looking at the four programmes and we want to have resources in place to support his work.